Skip to main content

Table 1 Baseline characteristics of patients wtih non-dialysis CKD stratified by serum phosphorus levels

From: Relationship between serum phosphorus and mortality in non-dialysis chronic kidney disease patients: evidence from NHANES 2001–2018

Variables a

Serum phosphorus, mg/dL

P value

 < 3.5 ( n  = 2395)

3.5 to < 4.5 ( n  = 4564)

 ≥ 4.5 ( n  = 735)

Age, yr

   

0.083

 18–65

1010(50.7)

1929(48.0)

358(52.7)

 

 ≥ 65

1385(49.3)

2635(52.0)

377(47.3)

 

Male, n (%)

1432(56.5)

1938(37.5)

241(29.7)

0.053

Race, n (%)

   

0.016

 non-Hispanic White

1107(67.7)

2368(71.9)

371(71.1)

 

 non-Hispanic Black

570(13.2)

927(11.3)

146(10.5)

 

 Mexican American

376(8.0)

592(6.2)

108(6.8)

 

 Other

342(11.1)

677(10.6)

110(11.6)

 

CKD stages

   

 < 0.001

 G1-2

1353(58.6)

2241(50.4)

318(44.4)

 

 G3a

740(30.9)

1533(34.8)

218(32.0)

 

 G3b

253( 8.8)

597(11.7)

111(14.5)

 

 G4

45(1.7)

183(3.0)

60(6.5)

 

 G5

4(0.1)

10(0.1)

28(2.7)

 

Hemoglobin, g/dL

14.2(0.0)

13.8(0.0)

13.5(0.1)

 < 0.001

Serum albumin, g/L

41.4(0.1)

41.6(0.1)

41.6(0.2)

0.152

Serum calcium, mmol/L

2.3(0.0)

2.4(0.0)

2.4(0.0)

 < 0.001

Parathyroid hormoneb, pg/mL

60.7(2.5)

53.3(1.3)

62.5(6.5)

0.023

25(OH) D, nmol/L

68.1(1.0)

70.6(0.8)

70.1(1.5)

0.054

Obesityc, n (%)

1080(47.4)

1910(42.3)

300(41.3)

0.004

Hypertension, n (%)

1716(68.2)

3247(66.1)

514(66.2)

0.432

Diabetes, n (%)

982(36.6)

1689(31.7)

300(34.2)

0.005

CVD, n (%)

658(24.0)

1260(24.2)

209(27.3)

0.317

  1. Abbreviation: CKD chronic kidney disease, CVD cardiovascular disease
  2. aAll estimates accounted for complex survey designs. Continuous variables were expressed as mean (standard error). Categorical variables were expressed as number (percent)
  3. bOnly provided in NHANES 2003–2006 (n = 1601)
  4. cObesity is defined as body mass index ≥ 30 kg/m2